Tian-ying Zhang

State Key Laboratory Of Vaccines For Infectious Diseases
Xiamen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responses.

Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responses.

Journal: British journal of pharmacology

Published: May 12, 2025

Immunological enhancement of micro-nanoparticle formulated with risedronate and zinc as vaccine adjuvant in aged mice.

Immunological enhancement of micro-nanoparticle formulated with risedronate and zinc as vaccine adjuvant in aged mice.

Journal: Immunity & ageing : I & A

Published: February 16, 2025

Palmitoylated COX-2Cys555 reprogrammed mitochondrial metabolism in pyroptotic inflammatory injury in patients with post-acute COVID-19 syndrome.

Palmitoylated COX-2Cys555 reprogrammed mitochondrial metabolism in pyroptotic inflammatory injury in patients with post-acute COVID-19 syndrome.

Journal: Journal of advanced research

Published: January 07, 2025

Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.

Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.

Journal: Signal transduction and targeted therapy

Published: August 24, 2023

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters.

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters.

Journal: Nature communications

Published: August 10, 2022

A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19.

A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19.

Journal: Cellular & molecular immunology

Published: June 30, 2022

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine.

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine.

Journal: Cell host & microbe

Published: June 09, 2022

Erratum: A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway: Erratum.

Erratum: A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway: Erratum.

Journal: Theranostics

Published: June 06, 2022

Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.

Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.

Journal: Emerging microbes & infections

Published: February 15, 2021

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters.

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters.

Journal: Science translational medicine

Published: December 11, 2020

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection.

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection.

Journal: Emerging microbes & infections

Published: December 09, 2020

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro.

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro.

Journal: Frontiers in pharmacology

Published: October 03, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026